Solara Active Pharma Sciences Limited (SOLARA) — Financial Results | 23 July 2026(2 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Audio recording of Q1 FY27 earnings call uploaded
💡 Investor Takeaway
Shareholders can listen to the call to understand management's commentary on quarterly performance.

Solara Active Pharma Sciences announced the audio recording of its Q1 FY27 earnings call held on July 23, 2026, for the quarter ended June 30, 2026, uploaded to its website under investor relations.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF
MetricValue
Revenue₹3,843 Cr
Net Profit (PAT)₹163 Cr
📢 Key Event
Solara reports Strong Q1’27 Base business performance with continued Growth and Profitability
🔄 What Changed
Net debt reduced by INR 1,346 Mn to INR 4,795 Mn; PAT up 55% YoY; EBITDA up 10% YoY
🔮 What's Next
Net debt expected to reach INR 4,406 Mn by Mar’27 with Net debt to EBITDA ratio ~1.7 times
💡 Investor Takeaway
Strong Base business growth and profitability offset Ibuprofen losses, with debt reduction improving financial resilience.

Solara Active Pharma reported Q1'27 overall revenue of INR 3,843 Mn, up 20% YoY, with EBITDA at INR 635 Mn (+10% YoY) and PAT at INR 163 Mn (+55% YoY), marking the highest EBITDA and PAT in the last eighteen quarters, driven by strong Base business performance despite commodity Ibuprofen headwinds.

About Solara Active Pharma Sciences Limited (SOLARA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹3,425.95 Cr ROE: -0.1% ROCE: 4.7%

View full SOLARA stock details →

📡 Get AI alerts when SOLARA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SOLARA — Free

📊 More SOLARA filings

See all SOLARA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SOLARA files new disclosures

Track SOLARA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SOLARA — Free

Free account · 2 AI queries/day